SOURCE: CDEX Inc.

July 08, 2008 08:00 ET

CDEX Inc. Updates Investors and Fields Questions in Teleconference Call-In Today, July 8, at 11:00 a.m. (EDT)

Recording of the Teleconference Will Be Placed on the CDEX Web Site at www.cdexinc.com

TUCSON, AZ--(Marketwire - July 8, 2008) - CDEX Inc. (OTCBB: CEXI) announces that today at 11:00 a.m. (EDT) it will hold a call-in teleconference to update investors and field questions regarding performance and the recent financing agreement. Malcolm Philips (CEO), Tim Shriver (COO) and Steve Schmidt (VP and GM, Security Division) will provide the briefing and respond to questions. Participants' dial-in numbers are 1-866-321-8231 or 416-624-5213 with the Confirmation Code being 4033661.

About CDEX Inc.

CDEX, a technology development company currently developing and marketing products using its patented/patent pending chemical detection technologies, is focused on (i) identification of substances of concern (e.g., explosives and illegal drugs, for security markets); and (ii) validation of substances for anti-counterfeiting, brand protection and quality assurance (e.g., validation of compounded medication and detection of counterfeit or sub-par products, for the medical and brand protection markets). ValiMed™ and the ID2 Meth Scanner™ are CDEX solutions for the medication safety and security markets. Corporate headquarters and R&D facilities are located in Tucson, Arizona. For more information, visit www.cdex-inc.com and www.valimed.com or contact Steve Schmidt (sschmidt@cdex-inc.com) at 520.745.5172.

Any Non-Historical statements are forward-looking, as defined in federal securities laws, and generally can be identified by words such as "expects," "plans," "may," "anticipates," "believes," "should," "intends," "estimates," and other similar words. These statements pose risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied. Such risks and uncertainties include, without limitation, the effectiveness, profitability and marketability of products, the Protection of intellectual property and proprietary information, and other risks detailed from time-to-time in filings with the Securities and Exchange Commission. There is no obligation to publicly update any forward-looking statements.

Contact Information